Neurabin 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
¶ title: Neurabin-1 Protein
description: Synaptic PP1 regulator critical for synaptic plasticity, spine morphology, and learning.
|
| Protein Name | Neurabin-1 (PPP1R9A) |
| Gene | PPP1R9A |
| UniProt ID | Q9Y5X4 |
| PDB ID | 2NBM |
| Molecular Weight | ~125 kDa (1028 amino acids) |
| Subcellular Localization | Cytoplasm, dendritic spines, postsynaptic density |
| Protein Family | PPP1 regulatory subunits, Spinophilin family |
Neurabin-1 (also known as PPP1R9A or Spinophilin) is a neuronal protein that serves as a key regulatory subunit of protein phosphatase 1 (PP1). It plays critical roles in synaptic plasticity, dendritic spine morphology, and learning and memory. Neurabin-1 is predominantly expressed in the brain, particularly in dendritic spines of excitatory synapses, where it modulates synaptic signaling and structure.
The protein was originally named Spinophilin due to its enrichment in dendritic spines, while Neurabin-1 (neuralabin) reflects its neuronal expression. Despite its name suggesting phosphatase inhibitory function, neurabin-1 has diverse roles beyond PP1 regulation.
Neurabin-1 possesses a multi-domain architecture:
¶ N-terminal Domain
- F-actin binding domain: Directs localization to dendritic spines
- PP1 binding motif (RVxF): Classic PP1 docking sequence
- Spine-targeting domain: Targets protein to postsynaptic sites
- Coiled-coil domain: Mediates protein-protein interactions
- Multiple proline-rich regions: Bind SH3 domain-containing proteins
¶ C-terminal Domain
- PDZ domain: Scaffold for postsynaptic protein complexes
- Additional PP1 interaction sites: Multiple PP1-binding surfaces
The structure reveals how neurabin-1 integrates multiple protein-protein interaction domains to form a postsynaptic signaling hub.
Neurabin-1 serves multiple essential functions in neurons:
As a PP1 regulatory subunit:
- Targeting PP1: Recruits PP1 to dendritic spines
- Substrate specificity: Modulates PP1 substrate selection
- Activity modulation: Regulates PP1 enzymatic activity
- Synaptic PP1 pools: Creates specialized PP1 microdomains
Neurabin-1 critically regulates:
- Long-term potentiation (LTP): Affects LTP induction and maintenance
- Long-term depression (LTD): Modulates LTD processes
- Synaptic strength: Regulates baseline synaptic transmission
- Dendritic spine dynamics: Controls spine formation and maintenance
Directly affects dendritic spine structure:
- Spine number: Regulates spine density
- Spine shape: Affects mushroom, stubby, and thin spine proportions
- Postsynaptic density: Organizes PSD proteins
- Actin cytoskeleton: Links to spine actin dynamics
¶ Learning and Memory
Essential for cognitive function:
- Spatial learning: Required for spatial memory formation
- Contextual fear memory: Important for fear learning
- Behavioral flexibility: Affects adaptive behaviors
- Working memory: Modulates prefrontal cortical function
Neurabin-1 acts through multiple mechanisms:
By targeting PP1 to specific substrates:
- AMPA receptor regulation: Controls GluA1/GluA2 phosphorylation
- NMDA receptor modulation: Affects NMDA receptor function
- Synaptic scaffold proteins: Modulates PSD-95 and related proteins
- Kinase regulation: Controls CaMKII and other synaptic kinases
The PDZ domain scaffolds signaling complexes:
- Receptor clustering: Organizes glutamate receptors
- Signaling pathway assembly: Brings together kinases and phosphatases
- Cytoskeletal linkage: Connects receptors to actin
Beyond PP1:
- F-actin binding: Links to spine cytoskeleton
- SH3 domain proteins: Binds numerous SH3-containing partners
- Phosphatase complexes: Integrates with other phosphatases
Neurabin-1 has important connections to Alzheimer's disease:
- Synaptic dysfunction: Early target in AD pathophysiology
- Tau pathology: May be affected by tau aggregation
- AMPA receptor trafficking: Dysregulated in AD
- Learning deficits: Contributes to cognitive impairment
- Therapeutic target: Modulating neurabin-1 may improve synaptic function
In Parkinson's disease:
- Dopaminergic signaling: Modulates striatal synaptic plasticity
- Learning deficits: Cont symptoms
- Synributes to cognitiveaptic homeostasis: May be affected in PD
- Basal ganglia function: Important for motor learning
ALS connections:
- Motor neuron synapses: Early synaptic dysfunction in ALS
- Spine pathology: Altered spine morphology in models
- Synaptic protein aggregates: May be affected by TDP-43 pathology
- Striatal synapses: Critical for striatal function
- Dendritic pathology: Altered spine morphology in HD
- Learning deficits: Contributes to cognitive symptoms
- Synaptogenesis: Critical for proper synapse formation
- Cognitive development: Essential for learning
- Autism spectrum disorders: Associated with some ASD risk variants
Neurabin-1 represents a therapeutic target:
- Synaptic enhancement: PP1 modulators to improve synaptic function
- Spine stabilization: Preventing spine loss in disease
- Cognitive improvement: Addressing cognitive symptoms
- Depression: Altered PP1 signaling in depression models
- Schizophrenia: Synaptic dysfunction hypothesis
- Anxiety disorders: Amygdala synaptic plasticity
- Stroke recovery: Enhancing synaptic plasticity during rehabilitation
- Traumatic brain injury: Supporting synaptic repair
- Spinal cord injury: Promoting functional recovery
¶ Interactions and Network
Neurabin-1 interacts with numerous proteins:
- Protein Phosphatase 1 (PP1): Primary binding partner
- Glutamate receptors: NMDA and AMPA receptor subunits
- PSD-95: Postsynaptic scaffold
- F-actin: Spine cytoskeleton
- Kalirin: Rho guanine nucleotide exchange factor
- Spinophilin: Same protein (alternative name)
- NMDAR subunits: GluN2A, GluN2B
Current research areas include:
- Structure-function studies: Elucidating domain functions
- Therapeutic targeting: Developing neurabin-1 modulators
- Disease mechanisms: Neurabin-1 in neurodegeneration
- Synapse biology: Understanding spine-specific PP1 pools
- Behavior: Neurabin-1 in specific learning paradigms
The study of Neurabin 1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Allen et al., Neurabin: A synaptic PP1 regulator (1997)
- Feng et al., Spinophilin is required for various learning tasks (2000)
- Ragusa et al., Spinophilin in dendritic spine morphology (2010)
- Dagda et al., Spinophilin in neurodegeneration (2013)
- Oaks et al., Neurabin in psychiatric disorders (2020)
- Hu et al., Spinophilin in Alzheimer's disease (2021)